News Release 

Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for COVID-19

JAMA Cardiology

What The Study Did: The association between angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and the severity of illness and death in patients with hypertension hospitalized for COVID-19 is examined in this study.

Authors: Aiping Deng, of the Central Hospital of Wuhan in China, is the corresponding author.

To access the embargoed study:  Visit our For The Media website at this link https://media.jamanetwork.com/ 

(doi:10.1001/jamacardio.2020.1624)

Editor's Note: Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

###

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2020.1624?guestAccessKey=4f4dde38-ca01-4f16-95a3-8b4b67e96cb7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042320

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.